acetylcysteinyl-leucyl-glutamyl-glutamyl-prolyl-cysteine methyl ester cyclic disulfide

Known as: ACLGGPCM, Ac-Cys-Leu-Glu-Glu-Pro-Cys-OMe cyclic disulfide, L-Cysteine, N-acetyl-L-cysteinyl-L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-prolyl-, 6-methyl ester, cyclic (1-6)-disulfide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
0119932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Genome mining of the mithramycin producer Streptomyces argillaceus ATCC 12956 revealed 31 gene clusters for the biosynthesis of… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2004
2004
Tryptamine-4,5-dione (1) is formed by oxidation of 5-hydroxytryptamine by reactive oxygen and reactive nitrogen species. Dione 1… (More)
Is this relevant?
2003
2003
Following the administration of 2-, 3- and 4-fluorobenzyl alcohols, the major metabolites detected in urine corresponded to the… (More)
Is this relevant?
2001
2001
1,3-Butadiene (BD), which is used to make styrene-butadiene rubber, is a potent carcinogen in mice and a probable carcinogen… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1999
1999
Increased catechol thioether formation is associated with Parkinson's disease. In this study, we examined whether catechol… (More)
Is this relevant?
1996
1996
A very early event in the pathogenesis of idiopathic Parkinson's disease (PD) has been proposed to be an elevated translocation… (More)
Is this relevant?
1995
1995
An integrated population monitoring study was initiated to investigate whether occupational exposure to current low levels of… (More)
Is this relevant?
1994
1994
We have previously identified two metabolites, 1,2-dihydroxy-4-(N-acetylcysteinyl-S-)-butane (M-I) and 1-hydroxy-2-(N… (More)
Is this relevant?
1993
1993
Epidemiological evidence indicates that 1,3-butadiene is a human carcinogen; however, the epidemiological studies reflect past… (More)
Is this relevant?